Brief: Xortx Announces Positive Topline Results From Xrx-Oxy-101 Clinical Trial

XORTX Therapeutics

19/01/2023 12:49

Jan 19 (Reuters) - XORTX Therapeutics Inc  XRTX.V :
    * XORTX ANNOUNCES POSITIVE TOPLINE RESULTS FROM XRX-OXY-101
CLINICAL TRIAL
    * XORTX THERAPEUTICS INC - RESULTS FROM STUDY SHOWED THAT
XORLOTM
WAS WELL TOLERATED ACROSS VARIOUS DOSING REGIMENS
    * XORTX THERAPEUTICS INC - NO SAFETY ISSUES WERE IDENTIFIED
IN ANY
OF FOUR PARTS OF STUDY ON 88 SUBJECTS WHO RECEIVED DRUG

Source text for Eikon:  ID:nGNX109M3q 
Further company coverage:  XRTX.V 
 ((Reuters.Briefs@thomsonreuters.com;))